| [1] van der Bruggen P，Traversari C，Chomez P，et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma[J]. Science，1991，254 (5038)：1643-1647. [2] Chomez P，De Backer O，Bertrand M，et al. An overview of the MAGE gene family with the identification of all human members of the family[J]. Cancer Res，2001，61 (14)：5544-5551. [3] Barker PA，Salehi A. The MAGE proteins：emerging roles in cell cycle progression，apoptosis，and neurogenetic disease[J]. J Neurosci Res， 2002，67 (6)：705-712. [4] Brasseur F，Rimoldi D，Liénard D，et al. Expression of MAGE genes in primary and metastatic cutaneous melanoma[J]. Int J Cancer，1995， 63 (3)：375-380. [5] Jang SJ，Soria JC，Wang L，et al. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis[J]. Cancer Res， 2001，61 (21)：7959-7963. [6] Otte M，Zafrakas M，Riethdorf L，et al. MAGE-A gene expression pattern in primary breast cancer[J]. Cancer Res，2001，61 (18)： 6682-6687. [7] Lin J，Lin L，Thomas DG，et al. Melanomaassociated antigens in esophageal adenocarcinoma：identification of novel MAGE-A10 splice variants[J]. Clin Cancer Res，2004，10 (17)：5708-5716. [8] Bergeron A，Picard V，LaRue H，et al. High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer[J]. Int J Cancer，2009，125 (6)：1365-1371. [9] Suyama T，Ohashi H，Nagai H，et al. The MAGE-A1 gene expression is not determined solely by methylation status of the promoter region in hematological malignancies[J]. Leuk Res，2002，26 (12)：1113-1118. [10] Sang M，Wang L，Ding C，et al. Melanoma-associated antigen genes-an update[J]. Cancer Lett，2011，302 (2)：85-90. [11] DeSmet C，Lurquin C，Lethe B，et al. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter[J]. Mol. Cell Biol，1999，19 (11)：7327-7335. [12] James SR，Link PA，Karpf AR. Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b[J]. Oncogene， 2006，25 (52)：6975-6985. [13] Gaudet F，Hodgson JG，Eden A，et al. Induction of tumors in mice by genomic hypomethylation[J]. Science，2003，300 (5618)：489-492. [14] Nakanish IM，Ozak IT，Yamamoto H，et al. NFBD 1 /MDC 1 associa tes with p53 and regulates its function at the cross road between cell survival and death in response to DNA damage [J]. J Boil Chem， 2007， 282 (31)：22993-23004. [15] Irwin MS，Kaelin WG. p53 family update：p73 and p63 develop their own identities [J]. Cell Growth Differ，2001，12 (7)：337-349. [16] Laurenz IVD，CoStanzo A，Barcarol ID，et al. Two new p73 splice variants，gamma and delta，with different transcriptional activity [J]. J Exp Med，1998，188 (9)：1763-1768. [17] Monte M，Simonatto M，Peche LY，et al. MAGE-a tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents[J]. Proc Natl Acad Sci USA，2006，103 (30)：11160-11165. [18] Sakurai T，Itoh K，Higashitsuji H，et al. A cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells[J]. J Biol Chem， 2004，279 (15)：15505-15514. [19] Peche LY，Scolz M，Ladelfa MF，et al. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs[J]. Cell Death Differ，2012，19 (6)：926-936. [20] Yang B，O’Herrin SM，Wu J，et al. MAGE-A，mMAGE-B，and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines[J]. Cancer Res， 2007， 67 (20)：9954-9962. [21] Wang C，Ivanov A，Chen L，et al. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation[J]. Embo J，2005，24 (18)：3279-3290. [22] Wang C，Rauscher FJ，Cress WD，et al. Regulation of E2F1 function by the nuclear corepressor KAP1[J]. J Biol Chem，2007，282 (41)： 29902-29909. [23] Doyle JM，Gao J，Wang J，et al. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases[J]. Mol Cell，2010，39 (6)：963-974. [24] Marcar L，Maclaine NJ，Hupp TR，et al. MAGE-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin[J]. Cancer Res，2010，70 (24)：10362-10370. [25] Ladelfa MF，Peche LY，Toledo MF，et al. Tumor-specific MAGE proteins as regulators of p53 function[J]. Cancer Letter，2012，325 (1)：11-17. [26] Taniura H，Matsumoto K，Yoshikawa K. Physical and functional interactions of neuronal growth suppressor necdin with p53[J]. J Biol Chem，1999，274 (23)：16242-16248. [27] Taniura H，Taniguchi N，Hara M，et al. NECDIN，a postmitotic neuron-specific growth suppressor，interacts with viral transforming proteins and cellular transcription factor E2F1[J]. J Biol Chem，1998， 273 (2)：720-728. [28] Ellis L，Pan Y，Smyth GK，et al. Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma[J]. Clin Cancer Res，2008，14 (14)：4500-4510. [29] Joseph J，Mudduluru G，Antony S，et al. Expression profiling of sodium butyrate (NaB)-treated cells：identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB[J]. Oncogene，2004，23 (37)：6304-6315. |
